Treatment of blepharospasm and Meige's syndrome with botulinum toxin: Experience and follow-up in 18 cases Tratamiento del Blefaroespasmo y Síndrome de Meige con toxina botulínica. Experiencia y seguimiento en 18 casos
Author
dc.contributor.author
Chana, Pedro
Author
dc.contributor.author
Kunstman, Carolina
Author
dc.contributor.author
Benavldes, Olga
Author
dc.contributor.author
Muñoz, Daniel S.
Author
dc.contributor.author
Tapia-Núñez, John
Admission date
dc.date.accessioned
2019-03-11T12:57:26Z
Available date
dc.date.available
2019-03-11T12:57:26Z
Publication date
dc.date.issued
2008
Cita de ítem
dc.identifier.citation
Revista Ecuatoriana de Neurologia, Volumen 17, Issue 1-3, 2018,
Identifier
dc.identifier.issn
10198113
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164723
Abstract
dc.description.abstract
Treatment with botulinum toxin (BT) is a good therapeutic alternative for patients with blepharospasm and Meige's syndrome. We report follow up results of 18 patients with blepharospasm and Meige's syndrome treated with botulinum toxin, to asses therapy response. 67 injection sessions were performed with a mean dose of 40.2 ± 26.5 Ul. The duration of effect was 120 ± 50 days and the global assessment of the results on a scale from 0 to 4 (0 no results to 4 very good results) was an average of 3.1 ± 0.72. We can say that botulinum toxin therapy was good or very good in 14 (77.7%) patients with blepharospasm and Meige's Syndrome. Only 3 cases (16.6%) had significative complications, reversible in all cases.
Treatment of blepharospasm and Meige's syndrome with botulinum toxin: Experience and follow-up in 18 cases Tratamiento del Blefaroespasmo y Síndrome de Meige con toxina botulínica. Experiencia y seguimiento en 18 casos